The EU legislation mandates that secondary drug packaging must have label information in Braille for sight-impaired customers. According to European Directive 2001/ 83/ EC Article 56A, pharmaceutical packaging will be required by law to have product names, formulation and strength displayed in Braille by October 2010.
“The EU requires that drug names be spelled out, so the uncontracted system was our obvious choice,” says Narendra Srivatsa, Cortegra’s director of packaging solutions. “We also had to use highly precise tooling, not only to make sure the characters were correct, but to make sure it was done without damaging the cartons.”
A subsidiary of Menasha Corporation, Cortegra has more than six decades of printing experience for the pharmaceutical industry. Its products include brand authentication technologies, labels, inserts and outserts, folding cartons, booklets and extended content labels.